Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Stock Information > Analyst Coverage

Analyst CoverageSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Firm Analyst
HC Wainwright & Co.   Reni Benjamin, PhD
Laidlaw & Company Ltd.   Edward White
RBC Capital Markets   Adnan Butt
ROTH Capital Markets   Joe Pantginis, Ph.D.
R. F. Lafferty & Co., Inc.   Difei Yang, PhD

Spectrum Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Spectrum Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Spectrum Pharmaceuticals, Inc. or its management. Spectrum Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
7.07
Change:
- 0.05
Day High:
7.17
Day Low:
7.03
Volume:
177,400
10:25 AM ET on Jul 24, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company